CC BY 4.0 · Rev Bras Ortop (Sao Paulo) 2024; 59(01): e17-e20
DOI: 10.1055/s-0044-1779311
Protocolo de Revisão Sistemática
Coluna

Efficacy of Dynamic Magnetic Resonance Imaging in the Diagnosis of Degenerative Cervical Myelopathy: Systematic Review Protocol*

Artikel in mehreren Sprachen: português | English
1   Divisão de Fisioterapia, Departamento de Ciências da Saúde, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
,
2   Divisão de Fisioterapia, Departamento de Ciências da Saúde, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
,
3   Departamento de Ortopedia e Anestesiologia, Doutoranda na Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
,
4   Divisão de Fisioterapia, Departamento de Ciências da Saúde, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
,
5   Departamento de Ortopedia e Anestesiologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
› Institutsangaben
Financial Support The present research has received no specific funding from agencies in the public, commercial, or not-for-profit sectors.

Abstract

Cervical degenerative myelopathy (CDM) is a cervical spine condition resulting in clinical manifestations of spinal cord compression related to the chronic, non-traumatic, and progressive narrowing of the cervical spinal canal. Conventional magnetic resonance imaging (MRI) is the gold standard test to diagnose and assess the severity of CDM. However, the patient is in a neutral and static position during the MRI scan, which may devalue the dynamic factors of CDM, underestimating the risk of spinal cord injury related to cervical spine flexion and extension movements. Dynamic MRI is a promising technique to change this scenario. Therefore, the present review aims to answer the following question: “Is dynamic MRI of the cervical spine more accurate in diagnosing CDM than conventional MRI?”. We will search for studies in the MEDLINE (via PubMed), Embase, Scopus, Web of Science, LILACS, and SciELO databases. The search strategy will contain a combination of terms related to cervical myelopathy and magnetic resonance imaging. Two independent reviewers will select studies, extract data, and assess the risk of bias. The synthesis of results will be descriptive, considering the main findings of the studies about the outcomes of interest.

Authors' Contributions

Each author contributed individually and significantly to the development of this article: VPGL – data acquisition, analysis, and interpretation; manuscript preparation; LPRO – data acquisition, analysis, and interpretation; MDSP – data analysis and interpretation; manuscript preparation and review; TPS – conception, design, and manuscript review; and CFPSH – conception, design, and manuscript review.


* Work developed at Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.




Publikationsverlauf

Eingereicht: 26. Februar 2023

Angenommen: 05. Mai 2023

Artikel online veröffentlicht:
21. März 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • Referências

  • 1 Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine 2015; 40 (12) E675-E693
  • 2 Tu J, Vargas Castillo J, Das A, Diwan AD. Degenerative Cervical Myelopathy: Insights into Its Pathobiology and Molecular Mechanisms. J Clin Med 2021; 10 (06) 1214
  • 3 Kolcun JP, Chieng LO, Madhavan K, Wang MY. The Role of Dynamic Magnetic Resonance Imaging in Cervical Spondylotic Myelopathy. Asian Spine J 2017; 11 (06) 1008-1015
  • 4 Lannon M, Kachur E. Degenerative Cervical Myelopathy: Clinical Presentation, Assessment, and Natural History. J Clin Med 2021; 10 (16) 3626
  • 5 Williams J, D'Amore P, Redlich N, Darlow M, Suwak P, Sarkovich S, Bhandutia AK. Degenerative Cervical Myelopathy: Evaluation and Management. Orthop Clin North Am 2022; 53 (04) 509-521
  • 6 Badhiwala JH, Ahuja CS, Akbar MA, Witiw CD, Nassiri F, Furlan JC. et al. Degenerative cervical myelopathy - update and future directions. Nat Rev Neurol 2020; 16 (02) 108-124
  • 7 Zhang L, Zeitoun D, Rangel A, Lazennec JY, Catonné Y, Pascal-Moussellard H. Preoperative evaluation of the cervical spondylotic myelopathy with flexion-extension magnetic resonance imaging: about a prospective study of fifty patients. Spine 2011; 36 (17) E1134-E1139
  • 8 Denno JJ, Meadows GR. Early diagnosis of cervical spondylotic myelopathy. A useful clinical sign. Spine 1991; 16 (12) 1353-1355
  • 9 Mackenzie WG, Dhawale AA, Demczko MM, Ditro C, Rogers KJ, Bober MB. et al. Flexion-extension cervical spine MRI in children with skeletal dysplasia: is it safe and effective?. J Pediatr Orthop 2013; 33 (01) 91-98
  • 10 Tykocki T, du Plessis J, Wynne-Jones G. Analysis of Morphometric Parameters in Cervical Canal Stenosis on Neutral and Dynamic Magnetic Resonance Imaging. World Neurosurg 2018; 114: e317-e322
  • 11 Pollock A, Berge E. How to do a systematic review. Int J Stroke 2018; 13 (02) 138-156
  • 12 Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898
  • 13 Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919
  • 14 Piggott T, Morgan RL, Cuello-Garcia CA, Santesso N, Mustafa RA, Meerpohl JJ. et al; GRADE Working Group. Grading of Recommendations Assessment, Development, and Evaluations (GRADE) notes: extremely serious, GRADE's terminology for rating down by three levels. J Clin Epidemiol 2020; 120: 116-120
  • 15 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
  • 16 PROSPERO International prospective register of systematic reviews. Available from: < https://www.crd.york.ac.uk/prospero/ >. [Acesso em: 05 de jan. de 2023] .